Drugs: In the Pipeline
Researchers and drugmakers have high hopes for many new monoclonal antibodies. These four are undergoing human testing or awaiting regulatory review by the FDA.
By Lauren Ware // Fall 2012
Pages
print
share:
previous
//
next
Page
print
share:
